Lupin Q4 net profit at ₹289 crore, misses estimates1 min read . Updated: 15 May 2019, 03:34 PM IST
- Revenues for Q4 increased to ₹4,406.3 crore in March quarter
- Lupin shares were down over 2% in late trade
Drugmaker Lupin swung to a profit in the fourth quarter ended March 31 but it missed the Street's estimates. Q4 net profit came in at ₹289.6 crore as compared to ₹783.5 crore loss in the same quarter of the previous year.
Revenues for Q4 increased to ₹4,406.3 crore in March quarter as compared to ₹4,033.8 crore in the year-ago quarter.
Shares of Lupin were down 2.5% at ₹788.75 in late trade.
North America sales in FY2019 were ₹5,592.4 crore, as compared to ₹5,893.9 crore in FY2018, accounting for 34% of global sales. In Q4 of FY2019, North America sales increased by 22.8% to ₹1740.6 crore, an increase of 16.1% as compared to Q4 FY2018.